265 related articles for article (PubMed ID: 31751390)
21. Molecular epidemiology study of Mycobacterium tuberculosis and its susceptibility to anti-tuberculosis drugs in Indonesia.
Lisdawati V; Puspandari N; Rif'ati L; Soekarno T; M M; K S; Ratnasari L; Izzatun N; Parwati I
BMC Infect Dis; 2015 Aug; 15():366. PubMed ID: 26297576
[TBL] [Abstract][Full Text] [Related]
22. The fourth national anti-tuberculosis drug resistance survey in Viet Nam.
Nhung NV; Hoa NB; Sy DN; Hennig CM; Dean AS
Int J Tuberc Lung Dis; 2015 Jun; 19(6):670-5. PubMed ID: 25946357
[TBL] [Abstract][Full Text] [Related]
23. Rates and risk factors for drug resistance tuberculosis in Northeastern China.
Liu Q; Zhu L; Shao Y; Song H; Li G; Zhou Y; Shi J; Zhong C; Chen C; Lu W
BMC Public Health; 2013 Dec; 13():1171. PubMed ID: 24330553
[TBL] [Abstract][Full Text] [Related]
24. Laboratory-Based Surveillance of Extensively Drug-Resistant Tuberculosis in Eastern China.
Huang Y; Wu Q; Xu S; Zhong J; Chen S; Xu J; Zhu L; He H; Wang X
Microb Drug Resist; 2017 Mar; 23(2):236-240. PubMed ID: 27754791
[TBL] [Abstract][Full Text] [Related]
25. Resistance pattern of multi-drug resistant strains of Mycobacterium tuberculosis and characteristics of patients with multi-drug resistant tuberculosis.
Moisoiu A; Mitran CI; Mitran MI; Huhu MR; Ioghen OC; Gheorghe AS; Tampa M; Georgescu SR; Popa MI
Roum Arch Microbiol Immunol; 2016; 75(1-2):25-31. PubMed ID: 29616530
[TBL] [Abstract][Full Text] [Related]
26. Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China.
Zhang Z; Pang Y; Wang Y; Liu C; Zhao Y
Int J Antimicrob Agents; 2014 Mar; 43(3):231-5. PubMed ID: 24439458
[TBL] [Abstract][Full Text] [Related]
27. First-line tuberculosis drug resistance patterns and associated risk factors in Germany, 2008-2017.
Glasauer S; Altmann D; Hauer B; Brodhun B; Haas W; Perumal N
PLoS One; 2019; 14(6):e0217597. PubMed ID: 31188848
[TBL] [Abstract][Full Text] [Related]
28. Multidrug-resistant tuberculosis of the spine--is it the beginning of the end? A study of twenty-five culture proven multidrug-resistant tuberculosis spine patients.
Pawar UM; Kundnani V; Agashe V; Nene A; Nene A
Spine (Phila Pa 1976); 2009 Oct; 34(22):E806-10. PubMed ID: 19829244
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011.
Nguyen HB; Nguyen NV; Tran HT; Nguyen HV; Bui QT
Western Pac Surveill Response J; 2016; 7(2):35-40. PubMed ID: 27508089
[TBL] [Abstract][Full Text] [Related]
30. First insights into the genetic characteristics and drug resistance of Mycobacterium tuberculosis population collected during the first national tuberculosis prevalence survey of Lao PDR (2010-2011).
Somphavong S; Berland JL; Gauthier M; Vu TT; Nguyen QH; Iem V; Vongvichit P; Inthavong D; Akkhavong V; Chanthavilay P; Soundala S; Keovichit I; Paranhos-Baccalà G; Paboriboune P; Nguyen TVA; Bañuls AL
BMC Infect Dis; 2019 Oct; 19(1):851. PubMed ID: 31615439
[TBL] [Abstract][Full Text] [Related]
31. Multi-drug resistant spinal tuberculosis-epidemiological characteristics of in-patients: a multicentre retrospective study.
Yang S; Yu Y; Ji Y; Luo DJ; Zhang ZY; Huang GP; He FY; Wu WJ; Mou XP
Epidemiol Infect; 2020 Jan; 148():e11. PubMed ID: 31983359
[TBL] [Abstract][Full Text] [Related]
32. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.
Mesfin EA; Beyene D; Tesfaye A; Admasu A; Addise D; Amare M; Dagne B; Yaregal Z; Tesfaye E; Tessema B
PLoS One; 2018; 13(6):e0197737. PubMed ID: 29864118
[TBL] [Abstract][Full Text] [Related]
33. Multi-drug resistant tuberculosis burden and risk factors: an update.
Marahatta SB
Kathmandu Univ Med J (KUMJ); 2010; 8(29):116-25. PubMed ID: 21209520
[TBL] [Abstract][Full Text] [Related]
34. Transmission of multi-drug resistant tuberculosis in Mongolia is driven by Beijing strains of Mycobacterium tuberculosis resistant to all first-line drugs.
Gurjav U; Erkhembayar B; Burneebaatar B; Narmandakh E; Tumenbayar O; Hill-Cawthorne GA; Marais BJ; Sintchenko V
Tuberculosis (Edinb); 2016 Dec; 101():49-53. PubMed ID: 27865397
[TBL] [Abstract][Full Text] [Related]
35. A study of clinical profile of cases of MDR-TB and evaluation of challenges faced in initiation of second line Anti tuberculosis treatment for MDR-TB cases admitted in drug resistance tuberculosis center.
Mukati S; Julka A; Varudkar HG; Singapurwala M; Agrawat JC; Bhandari D; Jain A
Indian J Tuberc; 2019 Jul; 66(3):358-363. PubMed ID: 31439180
[TBL] [Abstract][Full Text] [Related]
36. Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011.
Ulmasova DJ; Uzakova G; Tillyashayhov MN; Turaev L; van Gemert W; Hoffmann H; Zignol M; Kremer K; Gombogaram T; Gadoev J; du Cros P; Muslimova N; Jalolov A; Dadu A; de Colombani P; Telnov O; Slizkiy A; Kholikulov B; Dara M; Falzon D
Euro Surveill; 2013 Oct; 18(42):. PubMed ID: 24176581
[TBL] [Abstract][Full Text] [Related]
37. Resistance patterns among multidrug-resistant tuberculosis patients in greater metropolitan Mumbai: trends over time.
Dalal A; Pawaskar A; Das M; Desai R; Prabhudesai P; Chhajed P; Rajan S; Reddy D; Babu S; Jayalakshmi TK; Saranchuk P; Rodrigues C; Isaakidis P
PLoS One; 2015; 10(1):e0116798. PubMed ID: 25606853
[TBL] [Abstract][Full Text] [Related]
38. Regional differences of Mycobacterium tuberculosis complex infection and multidrug resistance epidemic in Luoyang.
Wang Z; Guo T; Xu L; Liu J; Hou Y; Jin J; Zhang Q; Jiang T; Zhao Z; Xue Y
BMC Infect Dis; 2024 Jun; 24(1):578. PubMed ID: 38862881
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of MDR-TB and XDR-TB in China: a prospective multicentre study.
Huang Z; Qin C; Du J; Luo Q; Wang Y; Zhang W; Zhang X; Xiong G; Chen J; Xu X; Li W; Li J
J Antimicrob Chemother; 2015 Feb; 70(2):456-62. PubMed ID: 25266071
[TBL] [Abstract][Full Text] [Related]
40. Risk factors associated with fluoroquinolone-resistant tuberculosis in a Beijing tuberculosis referral hospital.
Liu CH; Yang N; Wang Q; Hu YL; Li L; Zhang GY; Zhu B
Respirology; 2011 Aug; 16(6):918-25. PubMed ID: 21564401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
